Pfizer Attempt To Rid AHP Stalled By Warner-Lambert Buyout Nix
This article was originally published in The Rose Sheet
Executive Summary
Pfizer's $82.4 bil. bid for Warner-Lambert could bring the pharmaceutical giant back into the H&BA market, an area Pfizer all but vacated with the October sale of the Bain de Soleil sun care line to Schering-Plough.